...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)

NBB

In my experience with M&A, which I have had first hand quite a bit for what it's worth, companies don't typically buy another company to take it out.  

Why? Because that company must have value that they are worried about.  So instead of buying out to retire it...they buy it out to acquire.  And grow it.  That's how it's done   

10BagR

Share
New Message
Please login to post a reply